1. Home
  2. Analysis
  3. Predictions

Personalized prediction for a 69 year old woman who takes Bayer Low Dose Aspirin (81mg Aspirin), Rosuvastatin Calcium, Sotalol Hydrochloride, Vyvanse, Synthroid (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.

On Sep, 24, 2025, 8,303,570 related reports were analyzed:

What are the drugs?

What are the conditions?

What are the symtoms?

  • Loss of smell and taste: no further information found.

Potential side effects:

Atrial fibrillation/flutter
  • 7.02% for females aged 69 (±5) who have adhd and atrial flutter
  • 7.02% for females aged 69 (±5) who have hashimoto's disease and atrial flutter
Depression
  • 5.51% for females aged 69 (±5) who have adhd and hashimoto's disease
Diarrhea
  • 5.78% for females aged 69 (±5) who have hashimoto's disease
Dizziness
  • 8.68% for females aged 69 (±5) who have adhd and hashimoto's disease
Drowsiness
  • 5.77% for females aged 69 (±5) who have adhd and hashimoto's disease
Drug ineffective
  • 13.16% for females aged 69 (±5) who have adhd and hashimoto's disease
  • 5.1% for females aged 69 (±5) who take vyvanse
  • 5.1% for females aged 69 (±5) who take synthroid
  • 5.1% for females aged 69 (±5) who take bayer low dose aspirin (81mg aspirin)
  • 5.1% for females aged 69 (±5) who take rosuvastatin calcium
  • 5.1% for females aged 69 (±5) who take sotalol hydrochloride
Dyspnea
  • 5.57% for females aged 69 (±5) who have adhd and hashimoto's disease
Fall
  • 5.12% for females aged 69 (±5) who have adhd and hashimoto's disease
Fatigue
  • 14.71% for females aged 69 (±5) who have adhd and hashimoto's disease
  • 5.99% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
  • 5.82% for females aged 69 (±5) who have high cholesterol and adhd
  • 5.37% for females aged 69 (±5) who take bayer low dose aspirin (81mg aspirin)
  • 5.37% for females aged 69 (±5) who take vyvanse
  • 5.37% for females aged 69 (±5) who take synthroid
  • 5.37% for females aged 69 (±5) who take rosuvastatin calcium
  • 5.37% for females aged 69 (±5) who take sotalol hydrochloride
  • 5.08% for females aged 69 (±5) who have high cholesterol and atrial flutter
Feeling abnormal
  • 6.55% for females aged 69 (±5) who have adhd and hashimoto's disease
Gastrointestinal haemorrhage
  • 12.78% for females aged 69 (±5) who have adhd and atrial flutter
  • 12.59% for females aged 69 (±5) who have hashimoto's disease and atrial flutter
Hair loss
  • 7.05% for females aged 69 (±5) who have hashimoto's disease
Headache
  • 10.11% for females aged 69 (±5) who have adhd and hashimoto's disease
Heart palpitations
  • 5.68% for females aged 69 (±5) who have hashimoto's disease
High blood pressure
  • 5.83% for females aged 69 (±5) who have adhd and hashimoto's disease
Insomnia
  • 6.35% for females aged 69 (±5) who have adhd and hashimoto's disease
Joint pain
  • 6.16% for females aged 69 (±5) who have adhd and hashimoto's disease
  • 5.02% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
Muscle aches
  • 5.33% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
  • 5.26% for females aged 69 (±5) who have high cholesterol and adhd
Nausea
  • 7.19% for females aged 69 (±5) who have adhd and hashimoto's disease
  • 5.62% for females aged 69 (±5) who take bayer low dose aspirin (81mg aspirin)
  • 5.62% for females aged 69 (±5) who take synthroid
  • 5.62% for females aged 69 (±5) who take rosuvastatin calcium
  • 5.62% for females aged 69 (±5) who take sotalol hydrochloride
  • 5.62% for females aged 69 (±5) who take vyvanse
  • 5.12% for females aged 69 (±5) who have high cholesterol and adhd
  • 5.11% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
Pain
  • 5.64% for females aged 69 (±5) who have adhd and hashimoto's disease
Pain in extremity
  • 5.47% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
  • 5.46% for females aged 69 (±5) who have high cholesterol and adhd
Rashes
  • 5.57% for females aged 69 (±5) who have hashimoto's disease
Stress and anxiety
  • 7.05% for females aged 69 (±5) who have adhd
Weakness
  • 6.29% for females aged 69 (±5) who have adhd and hashimoto's disease
  • 5.36% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
  • 5.28% for females aged 69 (±5) who have high cholesterol and adhd
Weight increased
  • 5.57% for females aged 69 (±5) who have adhd and hashimoto's disease

Potential co-existing conditions:

Asthma
  • 5.54% for females aged 69 (±5) who have adhd
Bipolar disorder
  • 5.54% for females aged 69 (±5) who have adhd
Chronic thyroiditis
  • 61.63% for females aged 69 (±5) who have adhd and hashimoto's disease
Diabetes
  • 9.62% for females aged 69 (±5) who have high cholesterol and adhd
  • 9.59% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
  • 7.94% for females aged 69 (±5) who have high cholesterol and atrial flutter
Gastroesophageal reflux disease
  • 10.22% for females aged 69 (±5) who have high cholesterol and adhd
  • 10.2% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
  • 8.06% for females aged 69 (±5) who have high cholesterol and atrial flutter
  • 7.19% for females aged 69 (±5) who have adhd and hashimoto's disease
High blood pressure
  • 25.54% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
  • 25.52% for females aged 69 (±5) who have high cholesterol and adhd
  • 22.47% for females aged 69 (±5) who have high cholesterol and atrial flutter
  • 17.37% for females aged 69 (±5) who have adhd and hashimoto's disease
  • 16.62% for females aged 69 (±5) who have hashimoto's disease and atrial flutter
  • 16.47% for females aged 69 (±5) who have adhd and atrial flutter
  • 5.09% for females aged 69 (±5) who take bayer low dose aspirin (81mg aspirin)
  • 5.09% for females aged 69 (±5) who take rosuvastatin calcium
  • 5.09% for females aged 69 (±5) who take sotalol hydrochloride
  • 5.09% for females aged 69 (±5) who take vyvanse
  • 5.09% for females aged 69 (±5) who take synthroid
Hypersensitivity
  • 6.38% for females aged 69 (±5) who have adhd
Pain
  • 9.2% for females aged 69 (±5) who have adhd and hashimoto's disease
  • 7.52% for females aged 69 (±5) who have high cholesterol and adhd
  • 7.47% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
  • 6.4% for females aged 69 (±5) who have high cholesterol and atrial flutter
Rheumatoid arthritis
  • 9.51% for females aged 69 (±5) who take bayer low dose aspirin (81mg aspirin)
  • 9.51% for females aged 69 (±5) who take rosuvastatin calcium
  • 9.51% for females aged 69 (±5) who take sotalol hydrochloride
  • 9.51% for females aged 69 (±5) who take vyvanse
  • 9.51% for females aged 69 (±5) who take synthroid
  • 9.33% for females aged 69 (±5) who have adhd and hashimoto's disease
  • 6.28% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
  • 6.24% for females aged 69 (±5) who have high cholesterol and adhd
  • 5.16% for females aged 69 (±5) who have high cholesterol and atrial flutter
Sleep disorder
  • 5.38% for females aged 69 (±5) who have adhd and hashimoto's disease
Stress and anxiety
  • 8.49% for females aged 69 (±5) who have adhd and hashimoto's disease
  • 5.48% for females aged 69 (±5) who have high cholesterol and adhd
  • 5.38% for females aged 69 (±5) who have high cholesterol and hashimoto's disease
Stroke
  • 30.28% for females aged 69 (±5) who have adhd and atrial flutter
  • 29.84% for females aged 69 (±5) who have hashimoto's disease and atrial flutter
  • 9.86% for females aged 69 (±5) who have high cholesterol and atrial flutter

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

Related publications that referenced our studies

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

Recent personalized studies on eHealthMe:

© 2025 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.